Dianthus Therapeutics, Inc. (DNTH) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 1.12B | 409.44M | 413.82M | 263.61M | 271M | 280.9M | 287.49M | 365.69M | 380.93M | 177.45M | 191.45M | 78.64M |
| Cash & Short-Term Investments | 1.11B | 404.3M | 402.61M | 257.39M | 263.23M | 275.24M | 281.12M | 360.71M | 377.04M | 173.72M | 189.87M | 77.59M |
| Cash Only | 627.67M | 51.09M | 55.98M | 13.24M | 10.12M | 22.79M | 33.67M | 314.17M | 329.72M | 132.32M | 157.28M | 62.63M |
| Short-Term Investments | 483.59M | 353.21M | 346.63M | 244.15M | 253.11M | 252.45M | 247.45M | 46.54M | 47.31M | 41.39M | 32.59M | 14.96M |
| Accounts Receivable | 1.31M | 102K | 5M | 39K | 1M | 807K | 1.29M | 1.68M | 876K | 478K | 751K | 0 |
| Days Sales Outstanding | 137.53 | 826.38 | 585.34 | 244.95 | 69.92 | 72.85 | 62.86 | 62.3 | 70.49 | 123.71 | 74.77 | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 5.04M | 6.21M | 111K | 392K | 1.13M | 1.39M | 0 | 0 | 504K | 0 | 1.04M |
| Total Non-Current Assets | 126.97M | 121.48M | 163.62M | 62.47M | 77.58M | 93.1M | 66.76M | 3.27M | 1.54M | 1.95M | 1.01M | 0 |
| Property, Plant & Equipment | 1.57M | 1.63M | 1.49M | 1.58M | 1.64M | 1.75M | 541K | 631K | 725K | 800K | 893K | 0 |
| Fixed Asset Turnover | 0.29x | 0.18x | 0.26x | 0.12x | 0.69x | 1.16x | 3.71x | 2.75x | 1.15x | 0.54x | 1.03x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 113.87M | 110.14M | 152.87M | 51.7M | 68.31M | 81.73M | 61.48M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 11.54M | 9.72M | 9.26M | 9.18M | 7.63M | 9.63M | 4.74M | 2.64M | 811K | 1.15M | 116K | 0 |
| Total Assets | 1.25B | 530.92M | 577.45M | 326.08M | 348.58M | 374.01M | 354.25M | 368.96M | 382.46M | 179.41M | 192.46M | 78.64M |
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x |
| Asset Growth % | 257.7% | 41.95% | 63.01% | -11.62% | -8.86% | 108.47% | 84.06% | 369.19% | 358.36% | 115.86% | 17.27% | -55.1% |
| Total Current Liabilities | 38.28M | 30.73M | 23.86M | 20.09M | 16.95M | 18.45M | 15.71M | 10.03M | 8.96M | 9.63M | 13.08M | 4.03M |
| Accounts Payable | 5.27M | 9.72M | 6.71M | 5.4M | 8.27M | 4.58M | 7.57M | 3.69M | 2.61M | 2.61M | 1.37M | 813K |
| Days Payables Outstanding | 8.88K | - | - | - | - | - | - | - | - | - | 5.28K | 1.03K |
| Short-Term Debt | 399K | 367K | 217K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 1.49M | 1.19M | 954K | 479K | 479K | 479K | 100K | 100K | 100K | 100K | 100K | 0 |
| Other Current Liabilities | 31.13M | 19.45M | 15.98M | 3.81M | 2.05M | 5.15M | 7.73M | 2.6M | 1.44M | 5.36M | 4.43M | 1.6M |
| Current Ratio | 29.25x | 13.32x | 17.35x | 13.12x | 15.99x | 15.22x | 18.30x | 36.46x | 42.52x | 18.42x | 14.64x | 19.49x |
| Quick Ratio | 29.25x | 13.32x | 17.35x | 13.12x | 15.99x | 15.22x | 18.30x | 36.46x | 42.52x | 18.42x | 14.64x | 19.49x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 7.29M | 6.79M | 7.14M | 2.9M | 3.02M | 3.08M | 640K | 712K | 816K | 904K | 1M | 0 |
| Long-Term Debt | 965K | 1.02M | 1.07M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 1.12M | 1.17M | 1.17M | 0 | 30K | 97K | 168K | 257K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 45.57M | 37.52M | 30.99M | 23M | 19.97M | 21.53M | 16.35M | 10.74M | 9.78M | 10.54M | 14.08M | 4.03M |
| Total Debt | 1.36M | 1.39M | 1.28M | 1.33M | 1.4M | 1.49M | 311K | 407K | 497K | 585K | 670K | 0 |
| Net Debt | -626.3M | -49.7M | -54.7M | -11.91M | -8.72M | -21.3M | -33.36M | -313.76M | -329.23M | -131.74M | -156.61M | -62.63M |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 1.2B | 493.4M | 546.45M | 303.08M | 328.61M | 352.48M | 337.9M | 358.22M | 372.69M | 168.87M | 178.38M | 74.6M |
| Equity Growth % | 265.58% | 39.98% | 61.72% | -15.39% | -11.83% | 108.73% | 89.42% | 380.16% | 381.14% | 129.27% | 43.83% | -45.01% |
| Book Value per Share | 25.01 | 13.05 | 14.46 | 8.46 | 9.18 | 10.06 | 9.87 | 10.47 | 14.52 | 37.28 | 45.66 | 19.68 |
| Total Shareholders' Equity | 1.2B | 493.4M | 546.45M | 303.08M | 328.61M | 352.48M | 337.9M | 358.22M | 372.69M | 168.87M | 178.38M | 74.6M |
| Common Stock | 54K | 43K | 43K | 32K | 32K | 31K | 29K | 29K | 29K | 15K | 15K | 61K |
| Retained Earnings | -377.56M | -336.73M | -272.3M | -235.53M | -203.9M | -174.39M | -145.95M | -120.78M | -103.17M | -89.42M | -78.86M | -434.48M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -575K | 489K | 163K | 98K | 270K | 106K | 681K | -37K | -27K | 47K | -4K | -3K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |